Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP

被引：297

作者：

Ko, YH ^{[1
]}

Smith, BL

Wang, YC

Pomper, MG

Rini, DA

Torbenson, MS

Hullihen, J

Pedersen, PL

机构：

[1] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA

[2] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA

[3] Johns Hopkins Univ, Sch Med, Dept Art Appl Med, Baltimore, MD 21205 USA

[4] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2004年 / 324卷 / 01期

关键词：

advanced cancers; liver/colon cancer; cancer therapy; 3-bromopyruvic acid; ATP depletion;

D O I：

10.1016/j.bbrc.2004.09.047

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A common feature of many advanced cancers is their enhanced capacity to metabolize glucose to lactic acid. In a challenging study designed to assess whether such cancers can be debilitated, we seeded hepatocellular carcinoma cells expressing the highly glycolytic phenotype into two different locations of young rats. Advanced cancers (2-3 cm) developed and were treated with the alkylating agent 3-bromopyruvate, a lactate/pyruvate analog shown here to selectively deplete ATP and induce cell death. In all 19 treated animals advanced cancers were eradicated without apparent toxicity or recurrence. These findings attest to the feasibility of completely destroying advanced, highly glycolytic cancers. (C) 2004 Elsevier Inc. All rights reserved.

引用

页码：269 / 275

页数：7

共 15 条

[1] Focus on hepatocellular carcinoma [J].

Bruix, J ;

Boix, L ;

Sala, M ;

Llovet, JM .

CANCER CELL, 2004, 5 (03) :215-219

[2] HIGH AEROBIC GLYCOLYSIS OF RAT HEPATOMA-CELLS IN CULTURE - ROLE OF MITOCHONDRIAL HEXOKINASE - (L-LACTIC ACID-D-GLUCOSE-D-GALACTOSE-LIVER-NEOPLASIA) [J].

BUSTAMANTE, E ;

PEDERSEN, PL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (09) :3735-3739

[3]

Geschwind JFH, 2002, CANCER RES, V62, P3909

[4]

Hebel R, 1976, ANATOMY LAB RAT

[5] ALKYLATION OF ISOCITRATE LYASE FROM ESCHERICHIA-COLI BY 3-BROMOPYRUVATE [J].

KO, YH ;

MCFADDEN, BA .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1990, 278 (02) :373-380

[6] Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase [J].

Ko, YH ;

Pedersen, PL ;

Geschwind, JF .

CANCER LETTERS, 2001, 173 (01) :83-91

[7]

Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190

[8] Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention [J].

Pedersen, PL ;

Mathupala, S ;

Rempel, A ;

Geschwind, JF ;

Ko, YH .

BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2002, 1555 (1-3) :14-20

[9] Clinical applications of PET in oncology [J].

Rohren, EM ;

Turkington, TG ;

Coleman, RE .

RADIOLOGY, 2004, 231 (02) :305-332

[10]

Shimoji K, 2004, J NUCL MED, V45, P665

← 1 2 →